Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan

Ethics-Guided Radiation Therapy (EGRT): A proposal to refine the practice

Transforming cancer care in Africa: The ECHO project

ESMO and WCLC: Latest developments in EGFR mutated NSCLC

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours

New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients

Tusamitamab ravtansine versus docetaxel in previously treated advanced nonsquamous NSCLC: Results from phase 3 CARMEN-LC03 trial

Cemiplimab monotherapy could be a new treatment option for first line advanced NSCLC patients

Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients

Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC